← Back to Discover

Elmind Capital, LP

Period ended Sep 30, 2026 · Latest filing Nov 16, 2026

These quarterly holdings are delayed and may not include all assets or short positions. Values are from the reporting date, not current prices or purchase costs. The same security may appear in multiple rows.

Source: SEC

Reported portfolio value

Quarter-end reported holdings; not current value or investment performance.

View reported values
  • Sep 30, 2026: $403,836,290

More quarters will appear as history becomes available.

Top holdings

Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.

View top holdings values
  1. CELLDEX THERAPEUTICS INC NEW · COM NEW · 15117B202 · shares: $35,975,100
  2. LEGEND BIOTECH CORP · SPONSORED ADS · 52490G102 · shares: $31,220,856
  3. SYNDAX PHARMACEUTICALS INC · COM · 87164F105 · shares: $30,174,000
  4. COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $27,753,079
  5. RELAY THERAPEUTICS INC · COM · 75943R102 · shares: $26,448,286
  6. AMYLYX PHARMACEUTICALS INC · COM · 03237H101 · shares: $26,037,516
  7. VIRIDIAN THERAPEUTICS INC · COM · 92790C104 · shares: $25,221,329
  8. VAXCYTE INC · COM · 92243G108 · shares: $21,186,146
  9. UROGEN PHARMA LTD · COM · M96088105 · shares: $19,953,393
  10. TRAVERE THERAPEUTICS INC · COM · 89422G107 · shares: $18,994,688

Reported holdings

30 reported entries
IssuerClassCUSIPTypeShares / principalReported value (USD)
CELLDEX THERAPEUTICS INC NEWCOM NEW15117B202 — 1,110,000 shares $35,975,100
LEGEND BIOTECH CORPSPONSORED ADS52490G102 — 1,569,676 shares $31,220,856
SYNDAX PHARMACEUTICALS INCCOM87164F105 — 1,605,000 shares $30,174,000
COGENT BIOSCIENCES INCCOM19240Q201 — 866,742 shares $27,753,079
RELAY THERAPEUTICS INCCOM75943R102 — 1,465,279 shares $26,448,286
AMYLYX PHARMACEUTICALS INCCOM03237H101 — 894,760 shares $26,037,516
VIRIDIAN THERAPEUTICS INCCOM92790C104 — 1,224,931 shares $25,221,329
VAXCYTE INCCOM92243G108 — 372,340 shares $21,186,146
UROGEN PHARMA LTDCOMM96088105 — 491,100 shares $19,953,393
TRAVERE THERAPEUTICS INCCOM89422G107 — 322,600 shares $18,994,688
CULLINAN THERAPEUTICS INCCOM230031106 — 962,792 shares $14,778,857
PHARVARIS N VCOMN69605108 — 455,750 shares $14,456,390
VERA THERAPEUTICS INCCL A92337R101 — 436,518 shares $14,095,166
CYTOMX THERAPEUTICS INC.COM23284F105 — 4,550,000 shares $12,376,000
BEAM THERAPEUTICS INCCOM07373V105 — 476,338 shares $11,646,464
NURIX THERAPEUTICS INCCOM67080M103 — 460,000 shares $10,906,600
SUMMIT THERAPEUTICS INCCOM86627T108 — 493,820 shares $8,350,496
UNITED THERAPEUTICS CORP DELCOM91307C102 — 15,000 shares $8,128,350
IMMUNOCORE HLDGS PLCADS45258D105 — 256,143 shares $7,758,571
KRYSTAL BIOTECH INCCOM501147102 — 22,000 shares $7,316,320
ALUMIS INCCOM022307102 — 749,560 shares $5,539,248
BIOCRYST PHARMACEUTICALS INCCOM09058V103 — 520,000 shares $4,331,600
SUTRO BIOPHARMA INCCOM SHS869367201 — 228,265 shares $3,677,349
MBX BIOSCIENCES INCCOM55287L101 — 61,000 shares $3,575,820
DBV TECHNOLOGIES S ASPONSORED ADS23306J309 — 265,000 shares $3,116,400
SUPERNUS PHARMACEUTICALSCOM868459108 — 70,000 shares $3,012,800
BIOMARIN PHARMACEUTICAL INCCOM09061G101 — 47,000 shares $2,820,000
SEPTERNA INCCOM81734D104 — 49,444 shares $1,934,744
ALECTOR INCCOM014442107 — 915,902 shares $1,694,419
DESIGN THERAPEUTICS INCCOM25056L103 — 107,900 shares $1,356,303